Pending a green light from the FDA, Florida pharmaceuticals manufacturer will begin collecting new applications from other drug companies, says CEO David Daniel Ambrose.
(PRWeb April 17, 2012)
Read the full story at http://www.prweb.com/releases/david-daniel-ambrose/david-daniel-ambrose/prweb9373282.htm